Linköping University Hospital is a university hospital in Linköping, Sweden, operated by Östergötland County. Its scientific activities are integrated into the medical faculty of Linköping University. The hospital has all specializations except organ transplantation.

During the past decade, Universitetssjukhuset i Linköping, Hematologkliniken conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitetssjukhuset i Linköping, Hematologkliniken" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Janssen-Cilag Ltd." with 1 trials as a collaborator and "Nordic Cancer Union" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Universitetssjukhuset i Linköping, Hematologkliniken" are "Chronic Lymphocytic Leukemia" (2 trials), "Multiple Myeloma" (2 trials), "DLBCL" (1 trials), "Diffuse Large B Cell Lymphoma" (1 trials) and "MCL" (1 trials). Many other conditions were trialed in "Universitetssjukhuset i Linköping, Hematologkliniken" in a lesser frequency.

Most popular intervention types in "Universitetssjukhuset i Linköping, Hematologkliniken" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma" (1 trials), "Bendamustine" (1 trials), "Chlorambucil" (1 trials) and "Fludarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitetssjukhuset i Linköping, Hematologkliniken" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Universitetssjukhuset i Linköping, Hematologkliniken". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universitetssjukhuset i Linköping, Hematologkliniken, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitetssjukhuset i Linköping, Hematologkliniken, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".